PMC:7795856 / 14991-15256 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"269","span":{"begin":136,"end":143},"obj":"Gene"}],"attributes":[{"id":"A269","pred":"tao:has_database_id","subj":"269","obj":"Gene:3630"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":" to classical approaches, which involve the use of an insoluble fusion partner, for example, an α-galactosidase fragment in the case of insulin [43], to provoke formation of inclusion bodies and protect the gene product from intracellular proteolysis, the PASylated"}